These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 15630600)
1. [Nightmares in patients with Alzheimer's disease caused by donepezil. Therapeutic effect depends on the time of intake]. Singer M; Romero B; Koenig E; Förstl H; Brunner H Nervenarzt; 2005 Sep; 76(9):1127-8, 1129. PubMed ID: 15630600 [TBL] [Abstract][Full Text] [Related]
7. A case of donepezil-related torsades de pointes. Kitt J; Irons R; Al-Obaidi M; Missouris C BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26438681 [TBL] [Abstract][Full Text] [Related]
8. Extrapyramidal side-effect due to drug combination of risperidone and donepezil. Liu HC; Lin SK; Sung SM Psychiatry Clin Neurosci; 2002 Aug; 56(4):479. PubMed ID: 12109969 [No Abstract] [Full Text] [Related]
9. Aricept-induced nightmares in Alzheimer's disease: 2 case reports. Ross JS; Shua-Haim JR J Am Geriatr Soc; 1998 Jan; 46(1):119-20. PubMed ID: 9434681 [No Abstract] [Full Text] [Related]
10. Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial. Homma A; Atarashi H; Kubota N; Nakai K; Takase T J Alzheimers Dis; 2016 Mar; 52(1):345-57. PubMed ID: 26967222 [TBL] [Abstract][Full Text] [Related]
11. Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer's disease. Tariot P; Salloway S; Yardley J; Mackell J; Moline M BMC Res Notes; 2012 Jun; 5():283. PubMed ID: 22681723 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of donepezil in patients with Alzheimer's disease in assisted living facilities. Rosenblatt A; Gao J; Mackell J; Richardson S Am J Alzheimers Dis Other Demen; 2010 Sep; 25(6):483-9. PubMed ID: 20558849 [TBL] [Abstract][Full Text] [Related]
13. How the FDA forgot the evidence: the case of donepezil 23 mg. Schwartz LM; Woloshin S BMJ; 2012 Mar; 344():e1086. PubMed ID: 22442352 [No Abstract] [Full Text] [Related]
14. [Effects of anti-dementia drugs on sleep-wake patterns in sleep-disturbed rats]. Ishida T; Takeda Y; Hirase M; Kamei C Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Feb; 29(1):17-22. PubMed ID: 19326812 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study. Boada-Rovira M; Brodaty H; Cras P; Baloyannis S; Emre M; Zhang R; Bahra R; Drugs Aging; 2004; 21(1):43-53. PubMed ID: 14715043 [TBL] [Abstract][Full Text] [Related]
16. Donepezil 23 mg: a brief insight on efficacy and safety concerns. Nguyen MD; Salbu RL Consult Pharm; 2013 Dec; 28(12):800-3. PubMed ID: 24322964 [TBL] [Abstract][Full Text] [Related]
17. Characteristic effects of anti-dementia drugs on rat sleep patterns. Ishida T; Kamei C J Pharmacol Sci; 2009 Mar; 109(3):449-55. PubMed ID: 19305123 [TBL] [Abstract][Full Text] [Related]
18. Drug-induced lupus erythematosus associated with donepezil: a case report. Manzo C; Putignano S Age Ageing; 2015 Nov; 44(6):1062-3. PubMed ID: 26420637 [TBL] [Abstract][Full Text] [Related]
19. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. Rodda J; Morgan S; Walker Z Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824 [TBL] [Abstract][Full Text] [Related]
20. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease. Bullock R; Bergman H; Touchon J; Gambina G; He Y; Nagel J; Lane R Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]